The Australian National University (ANU) has announced a new research project with Janssen Research & Development, LLC, aimed at improving health outcomes in Type 1 Diabetes (T1D).

The collaboration was facilitated by Johnson & Johnson Innovation.

The project will focus on the development of new methods for measuring and monitoring disease activity. 

Type 1 Diabetes is an autoimmune disease that attacks the body’s ability to process sugar by destroying insulin-producing beta cells in the pancreas. 

Researchers from ANU will test new methods of monitoring this damage, as part of the wider effort to develop preventive measures and therapies.

Together with Janssen scientists, researchers from ANU aim to identify individuals at risk of T1D and track markers and influences in childhood to identify the opportunity and means to intervene early in the course of disease.

“The goal of this initiative is to discover avenues for interception that will enable a brighter future for individuals at risk of developing symptomatic T1D,” said Charmaine Simeonovic, Associate Professor and Chief Investigator.

“Working together with Janssen offers a fantastic opportunity for us to improve the monitoring of early stages of Type 1 diabetes disease development, so that new therapies can be better used to intervene and prevent diabetes onset.”

Improvement of health monitoring and diagnosis in Type 1 Diabetes is a priority area for ANU, as well as a focus of investment through the Our Health in Our Hands initiative and inaugural ANU Grand Challenges Scheme.

This research project will also assist partnerships held with ACT Health and clinical collaborators worldwide.  

This project builds on work supported by the JDRF Australian Type 1 Diabetes Clinical Research Network and its mission to creating a world without Type 1 Diabetes.

Top image: Adona Gonzalez/Pixabay

Contact the media team

You may also like

Article Card Image

ANU Professor receives international recognition for work on tobacco control

Tackling tobacco smoking and e-cigarette use is all in a day's work for Professor Emily Banks.

Article Card Image

Study shows major financial burden of chronic conditions   

The cost of health care is a major burden for people living with chronic conditions and their carers, according to a new study from ANU.

Article Card Image

Potent new opioid identified by ANU experts 

A potent opioid detected in Canberra for the first time in September 2024 carries a high risk of overdose, warn chemists from ANU and CanTEST.

Subscribe to ANU Reporter